4.8 Article

Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis

Related references

Note: Only part of the references are listed.
Article Oncology

Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer

Nicola Gaynor et al.

Summary: This article reviews the use of immune checkpoint inhibitors as immunomodulatory agents for relieving immune suppression caused by tumors. These inhibitors have shown impressive results in various solid cancers, especially melanoma and non-small cell lung cancer. They have potential benefits for most cancer types and numerous clinical studies are being conducted to explore their efficacy. The article provides an overview of key clinical trials involving immune checkpoint inhibitors targeting PD-1, PD-L1, and CTLA-4, and discusses emerging therapies targeting these checkpoints as well as the status of immune checkpoint inhibitors in breast cancer.

SEMINARS IN CANCER BIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Lars Michel et al.

Summary: Cardiac immune-related adverse events (irAEs) are a growing concern in patients receiving immune checkpoint inhibition (ICI) targeting programmed death 1 (PD1). This study investigated the early consequences of PD1 inhibition on cardiac integrity and found that it disrupts cardiac immune homeostasis and impairs myocardial functional integrity. Blocking tumor necrosis factor alpha (TNF alpha) may be a potential approach to prevent ICI-related cardiotoxicity.

EUROPEAN HEART JOURNAL (2022)

Article Multidisciplinary Sciences

Androgen receptor activity in T cells limits checkpoint blockade efficacy

Xiangnan Guan et al.

Summary: Immune checkpoint blockade has revolutionized oncology by inducing durable anti-tumour immunity. In advanced prostate cancer patients, immunotherapy treatments have largely failed. However, inhibiting androgen receptor activity can increase the sensitivity of tumor-bearing hosts to checkpoint blockade therapy by enhancing CD8 T cell function and improving responsiveness to PD-1 targeted therapy.

NATURE (2022)

Letter Cardiac & Cardiovascular Systems

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

John R. Power et al.

CIRCULATION (2021)

Editorial Material Multidisciplinary Sciences

Sex differences in immune responses

Takehiro Takahashi et al.

SCIENCE (2021)

Article Oncology

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitors-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Spencer C. Wei et al.

Summary: This study presents a robust preclinical model of ICI-associated myocarditis that recapitulates the clinical syndrome. Using this model, researchers demonstrate that CTLA4 and PD-1 (ICI targets) functionally interact in the development of myocarditis, and intervention with CTLA4-Ig (abatacept) attenuates myocarditis, providing mechanistic rationale and preclinical support for therapeutic clinical studies.

CANCER DISCOVERY (2021)

Review Medicine, Research & Experimental

Immune checkpoint inhibitor-associated myocarditis: manifestations arms mechanisms

Javid Moslehi et al.

Summary: Immune checkpoint inhibitors have revolutionized the treatment of cancer, but associated toxicities like myocarditis pose challenges that require further research, predictive biomarker identification, and improved diagnostic and treatment strategies.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Medicine, General & Internal

A Novel Circulating MicroRNA for the Detection of Acute Myocarditis

Rafael Blanco-Dominguez et al.

Summary: By identifying a novel microRNA mmu-miR-721 in mice and its human homologue hsa-miR-Chr8:96 in patients with myocarditis, researchers found that this microRNA could effectively distinguish patients with myocarditis from those with myocardial infarction, providing a potential non-invasive diagnostic approach.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis A Narrative Review

Lorenz H. Lehmann et al.

Summary: ICIs have become an important treatment option for various cancer types, but their use is associated with the risk of myocarditis. The diagnosis of ICI-associated myocarditis can be challenging and relies on a combination of clinical suspicion, cardiac biomarkers, imaging, and endomyocardial biopsy. Combining different types of ICIs may increase the risk of developing myocarditis.

JAMA CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Circulating Mesencephalic Astrocyte-Derived Neurotrophic Factor Negatively Correlates With Atrial Apoptosis in Human Chronic Atrial Fibrillation

Changhui Wang et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury

Tomohiro Yokota et al.

Review Endocrinology & Metabolism

Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints

Lee-Shing Chang et al.

ENDOCRINE REVIEWS (2019)

Review Cardiac & Cardiovascular Systems

T cell checkpoint regulators in the heart

Nir Grabie et al.

CARDIOVASCULAR RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Cardiovascular toxicities associated with immune checkpoint inhibitors

Jiun-Ruey Hu et al.

CARDIOVASCULAR RESEARCH (2019)

Review Oncology

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Letter Oncology

Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis

Yoshito Zamami et al.

JAMA ONCOLOGY (2019)

Review Oncology

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

Ahmed Salem et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Review Oncology

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

Ahmed Salem et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Cardiac & Cardiovascular Systems

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed S. Mahmood et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Oncology

PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes

Shisuo Du et al.

JOURNAL OF THORACIC ONCOLOGY (2018)

Article Medicine, Research & Experimental

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade

Sara Valpione et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Macrophage migration inhibitory factor knockout attenuates endotoxin-induced cardiac dysfunction in mice

Jie Zhang et al.

KARDIOLOGIA POLSKA (2018)

Letter Medicine, General & Internal

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

Javid J. Moslehi et al.

LANCET (2018)

Review Medicine, Research & Experimental

Emerging Issues in AAV-Mediated In Vivo Gene Therapy

Pasqualina Colella et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Article Multidisciplinary Sciences

Poststroke delivery of MANF promotes functional recovery in rats

Kert Matlik et al.

SCIENCE ADVANCES (2018)

Review Immunology

The diverse functions of the PD1 inhibitory pathway

Arlene H. Sharpe et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Oncology

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy

Alessandra Lorenzon et al.

ONCOTARGET (2017)

Review Cardiac & Cardiovascular Systems

Genome Editing for the Study of Cardiovascular Diseases

Alexandra C. Chadwick et al.

CURRENT CARDIOLOGY REPORTS (2017)

Article Medicine, General & Internal

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. dbj Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Immunology

Sex differences in immune responses

Sabra L. Klein et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

Mouse models of colorectal cancer as preclinical models

Rebecca E. McIntyre et al.

BIOESSAYS (2015)

Review Medicine, Research & Experimental

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future

Lieping Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Oncology

Estrogen receptors and their implications in colorectal carcinogenesis

Francesco Caiazza et al.

FRONTIERS IN ONCOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Canonical Wnt Signaling Regulates Atrioventricular Junction Programming and Electrophysiological Properties

Benjamin S. Gillers et al.

CIRCULATION RESEARCH (2015)

Review Medical Laboratory Technology

Myostatin - From the Mighty Mouse to cardiovascular disease and cachexia

Thomas Bernd Dschietzig

CLINICA CHIMICA ACTA (2014)

Review Cardiac & Cardiovascular Systems

Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy

DeLisa Fairweather et al.

CURRENT PROBLEMS IN CARDIOLOGY (2013)

Article Pathology

Getting Leukocytes to the Site of Inflammation

W. A. Muller

VETERINARY PATHOLOGY (2013)

Article Oncology

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Nicola J. Clegg et al.

CANCER RESEARCH (2012)

Review Cardiac & Cardiovascular Systems

Cardiokines Recent Progress in Elucidating the Cardiac Secretome

Masayuki Shimano et al.

CIRCULATION (2012)

Editorial Material Medicine, General & Internal

Tumor Immunotherapy Directed at PD-1

Antoni Ribas

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Cardiac & Cardiovascular Systems

Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure

Christopher C. Glembotski

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)

Article Biochemical Research Methods

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson et al.

BIOINFORMATICS (2010)

Review Genetics & Heredity

Deconstructing repression: evolving models of co-repressor action

Valentina Perissi et al.

NATURE REVIEWS GENETICS (2010)

Article Cardiac & Cardiovascular Systems

Treatment with an estrogen receptor-beta-selective agonist is cardioprotective

Ivana Nikolic et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)

Article Biochemical Research Methods

Protocol for the fast chromatin immunoprecipitation (ChIP) method

Joel D. Nelson et al.

NATURE PROTOCOLS (2006)

Article Multidisciplinary Sciences

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

Y Iwai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)